RADNOR, Pa. - Mineralys Therapeutics , Inc. (NASDAQ:MLYS), a biopharmaceutical company specializing in the development of treatments for cardiovascular and kidney diseases, has announced the ...

Proposed changes to this list are open for consultation. Learn about the consultation and how to provide your feedback. The consultation closes on March 8, 2025. Drugs included on the list for ...

European Patent Office (EPO) grants EU Patent No. EP3583125 B1 covering the Company’s Fully Human Albumin Binding (FHAB®) ...

Statins, a class of cholesterol-lowering drugs, have no effect on kidney function, a research team led by the University of Iowa has found.

Statins, a class of cholesterol-lowering drugs, have no effect on kidney function, a research team led by the University of ...

The Safer Drugs Consumption Facility in Glasgow opened on 13 January, letting people take substances under supervision. The proposed value of its new contract is £4.8m - about £300,000 lower ...

A University of Iowa research team has found that a class of cholesterol-lowering drugs have no effect on kidney function.

C&EN’s tabulation follows approvals from the FDA’s Center for Drug Evaluation and Research; therefore, it does not include blood products, gene therapies, vaccines, and other therapies that ...

Stimulant medications are considered the first-line treatment for ADHD for some very good reasons. Here are 6 things to know about stimulant medications in ADHD. Attention Deficit Hyperactivity ...

Albumin use in patients with septic shock who had kidney impairment was associated with increased RRT (OR, 2.37) and with in-hospital mortality (OR, 1.21). Caution is urged with early albumin use ...

Sometimes you may receive a combination of therapies, or something else entirely. Oncology (cancer) drugs include a range of therapies and medications, such as chemotherapy drugs, targeted ...